IPP Bureau
Danone India sets record with 20,911 healthcare pledges to fight anemia
By IPP Bureau - April 05, 2026
The record-setting effort stems from Danone India’s nationwide ‘IRON UP!’ campaign
Cupid deposits Rs. 82.88 crore for strategic stake in Baazar Style Retail
By IPP Bureau - April 05, 2026
The deal gives Cupid immediate access to Style Baazar’s fast-growing network of over 260 stores
Senores makes bold US push with new federal-focused JV
By IPP Bureau - April 05, 2026
Company leadership is framing the move as transformational.
Innovent Biologics’ OLN324 shows breakthrough results in vision disease study
By IPP Bureau - April 05, 2026
The JADE trial enrolled 164 U.S. patients who initially received three monthly doses of OLN324 or faricimab, followed by 12 weeks off treatment with retreatment allowed only if disease recurred
Concord Biotech acquires Celliimune to accelerate DNA-engineered cancer therapies
By IPP Bureau - April 04, 2026
Rs 66 lakh acquisition will support DNA engineering and novel cell-gene therapy alternatives to conventional chemotherapy
Sun Pharma flags mixed Fibromun trial results, advances new Phase III study in soft tissue sarcoma
By IPP Bureau - April 04, 2026
The company has highlighted setbacks in Phase II studies while outlining fresh regulatory and late-stage development plans for Fibromun and Nidlegy
Jan Vishwas Bill 2026 decriminalises minor health sector offences, eases compliance burden
By IPP Bureau - April 04, 2026
Parliament clears reform bill replacing jail terms for procedural lapses with graded monetary penalties across key health laws
BASF Pharma Solutions announces up to 20% price hike on excipients and APIs
By IPP Bureau - April 04, 2026
The company said the increase—up to 20%—takes effect immediately, or as current contracts allow
Cipla strengthens US respiratory portfolio with final FDA nod for generic Nintedanib
By IPP Bureau - April 04, 2026
ANDA approval for 100 mg and 150 mg capsules targeting idiopathic pulmonary fibrosis opens access to a $3.76 billion market in USA
Abbott launches nationwide Vitamin C awareness campaign
By IPP Bureau - April 04, 2026
The company spotlights micronutrient’s role in immunity, skin and bone health through digital and radio outreach on National Vitamin C Day
Kauvery Hospital sets new benchmark in high-risk cardiac care
By IPP Bureau - April 04, 2026
71-year-old high-risk patient with atrial fibrillation and ventricular tachycardia discharged next day
Apollo Hospitals hosts specialist dialogue on vertigo diagnosis challenges
By IPP Bureau - April 04, 2026
Hands-on clinical workshop in Bengaluru brings together neurologists, ENT specialists and physicians
PHARMEXCIL Chintan Shivir in Hyderabad charts roadmap to scale India’s pharma exports
By IPP Bureau - April 04, 2026
Industry, policymakers focus on AI-led regulatory harmonisation, FTAs, MSME support and market expansion as exports touch $28.29 billion till February FY26
ZEISS India strengthens portfolio with the launch of ZEISS ClearMind lenses
By IPP Bureau - April 03, 2026
Developed for today’s fast-paced, visually demanding lifestyles, the lenses are built on ZEISS NeurOptix technology
